SATYA TORAM: Open Payments
NPI 1225175029 · MODESTO, CA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$417 in 17 payments from 12 companies in 2025. Trend: 2023 $0 · 2024 $439 · 2025 $417
Food & beverage: $417
| Company | Payments | Amount |
|---|---|---|
| Radius Health, Inc. | 4 | $114 |
| Merck Sharp & Dohme LLC | 2 | $46 |
| PFIZER INC. | 2 | $41 |
| Lundbeck LLC | 1 | $35 |
| Astellas Pharma US Inc | 1 | $32 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 1 | $29 |
| Bayer Healthcare Pharmaceuticals Inc. | 1 | $24 |
| Dexcom, Inc. | 1 | $22 |
| Otsuka America Pharmaceutical, Inc. | 1 | $20 |
| SI-BONE, INC. | 1 | $20 |
Products named: Tymlos, REXULTI, PAXLOVID, Veozah, CAPLYTA, Kerendia, CAPVAXIVE, GARDASIL 9.
Industry payments across CA — which companies pay providers there.
